Glucose monitor maker Dexcom beats quarterly sales estimates, backs annual forecast

Medical device maker Dexcom (DXCM.O) beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous glucose monitors for diabetes patients and improved sales in international markets.